BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23806527)

  • 1. Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas.
    Dagher J; Dugay F; Verhoest G; Cabillic F; Jaillard S; Henry C; Arlot-Bonnemains Y; Bensalah K; Oger E; Vigneau C; Rioux-Leclercq N; Belaud-Rotureau MA
    Hum Pathol; 2013 Oct; 44(10):2106-15. PubMed ID: 23806527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
    de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
    Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
    Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
    Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
    Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma.
    Fukatsu A; Tsuzuki T; Sassa N; Nishikimi T; Kimura T; Majima T; Yoshino Y; Hattori R; Gotoh M
    Am J Clin Pathol; 2013 Oct; 140(4):500-5. PubMed ID: 24045546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
    Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
    Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of pathologic factors to efficacy of sorafenib treatment in patients with metastatic clear cell renal cell carcinoma.
    Araki H; Tsuzuki T; Kimura T; Tanaka K; Yamada S; Sassa N; Yoshino Y; Hattori R; Gotoh M
    Am J Clin Pathol; 2015 Apr; 143(4):492-9. PubMed ID: 25780000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
    Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
    Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
    Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
    Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.
    Nishikimi T; Tsuzuki T; Fujita T; Sassa N; Fukatsu A; Katsuno S; Yoshino Y; Hattori R; Gotoh M
    Pathol Int; 2011 Mar; 61(3):116-21. PubMed ID: 21355952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.
    Sperga M; Martinek P; Vanecek T; Grossmann P; Bauleth K; Perez-Montiel D; Alvarado-Cabrero I; Nevidovska K; Lietuvietis V; Hora M; Michal M; Petersson F; Kuroda N; Suster S; Branzovsky J; Hes O
    Virchows Arch; 2013 Oct; 463(4):563-73. PubMed ID: 23913167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
    Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
    J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
    Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
    Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.